Outcome of Therapies for Supratentorial Pleomorphic Xanthoastrocytomas in Children
This page was last updated on May 9th, 2017
Outcome After Surgery
70–80% overall survival rate with total resection for classical PXA: Gross total removal is the best chance for cure.
72% 5-year PFS: The progression-free survival rate is 72% at 5 years and 61% at 10 years (13). The 10-year overall survival rate for PXA is approximately 70% (13). The outcome is less favorable in cases of PXA with anaplastic features.
Recurrence more common: Overall, PXAs recur more commonly than do other low-grade gliomas (15-20%) (30, 31).
Unclear: The rarity of this tumor has not permitted the establishment of a standardized protocol for the use of adjuvant therapies. The roles of radiotherapy and chemotherapy have to be further investigated in anaplastic and recurrent PXAs.
Outcome After Multimodality Therapies
No information: The inexperience with adjuvant therapies for PXAs means that there is no meaningful information about outcome after multimodality therapies.